Peptides explained in plain language
Not medical advice
/
/
Weight Loss

Weight Loss

GLP-1 medicines changed weight care, and a huge copycat market grew up around them. This is where to sort out the real thing from everything sold next to it.

Peptides you’ll hear about

Status as of October 2026. Rules are changing, so check the date on each article and the current rule on the FDA’s website.

PeptideStatusWhat to know
Semaglutide (Ozempic, Wegovy, Rybelsus)FDA-approvedWeekly injection or daily pill. The Wegovy pill was approved in December 2025.
Tirzepatide (Mounjaro, Zepbound)FDA-approvedActs on two gut-hormone receptors. Zepbound is also approved for sleep apnea in adults with obesity.
Liraglutide (Victoza, Saxenda)FDA-approvedAn older, once-daily GLP-1.
Compounded semaglutide or tirzepatideCompounded · RxSharply limited since the shortages were declared over in late 2024 and early 2025.
RetatrutideResearch-onlyNot approved. Lilly plans to file for approval in early 2027. Anything sold online now is not the trial drug.

Latest in Weight Loss

Compounded semaglutide after the shortage: what changed

FDA-approvedCompounded · Rx
Oct 2, 2026
3 min

How to spot a counterfeit Ozempic pen

FDA-approved
Oct 2, 2026
3 min

Nausea on a GLP-1: what’s common and what’s not

FDA-approvedCompounded · Rx
Oct 2, 2026
3 min

Retatrutide: why the vials sold online aren’t the trial drug

Research-only
Oct 2, 2026
3 min